MURINEDDU, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.821
AS - Asia 1.943
EU - Europa 1.665
SA - Sud America 1.583
AF - Africa 86
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 8.122
Nazione #
US - Stati Uniti d'America 2.764
BR - Brasile 1.425
CN - Cina 747
UA - Ucraina 679
SG - Singapore 627
DE - Germania 273
HK - Hong Kong 242
IT - Italia 225
SE - Svezia 138
FI - Finlandia 117
TR - Turchia 112
GB - Regno Unito 55
AR - Argentina 52
FR - Francia 50
BD - Bangladesh 34
IQ - Iraq 32
BE - Belgio 31
RU - Federazione Russa 25
EC - Ecuador 24
VE - Venezuela 24
ZA - Sudafrica 23
MA - Marocco 22
UZ - Uzbekistan 21
CO - Colombia 19
IN - India 17
MX - Messico 16
CA - Canada 15
KR - Corea 15
PK - Pakistan 14
CZ - Repubblica Ceca 13
AU - Australia 12
CL - Cile 12
KE - Kenya 11
DO - Repubblica Dominicana 10
JO - Giordania 10
PY - Paraguay 10
TN - Tunisia 10
EU - Europa 8
IR - Iran 8
AT - Austria 7
LB - Libano 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 6
KZ - Kazakistan 6
NL - Olanda 6
OM - Oman 6
PE - Perù 6
AZ - Azerbaigian 5
ES - Italia 5
JM - Giamaica 5
NP - Nepal 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
JP - Giappone 3
KG - Kirghizistan 3
NG - Nigeria 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
IE - Irlanda 2
KH - Cambogia 2
MN - Mongolia 2
PL - Polonia 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
MC - Monaco 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 8.120
Città #
Chandler 675
Jacksonville 417
Singapore 367
Hong Kong 242
Princeton 238
Dearborn 216
Nanjing 192
Ann Arbor 109
Wilmington 105
New York 82
Shanghai 77
Izmir 76
São Paulo 70
Sassari 63
Ashburn 58
Beijing 56
Nanchang 56
Shenyang 56
Rio de Janeiro 47
Woodbridge 46
Hebei 43
Belo Horizonte 42
Changsha 38
Brasília 33
Jiaxing 31
Brussels 30
Tianjin 29
Kunming 22
Boardman 21
Tashkent 21
Guarulhos 20
Helsinki 20
Andover 19
Ningbo 19
Santa Clara 19
Curitiba 18
Porto Alegre 18
Jinan 17
San Mateo 17
Santo André 17
Baghdad 16
Guangzhou 16
Hangzhou 16
Mountain View 16
Norwalk 16
Rome 16
Sorocaba 16
Ribeirão Preto 15
Seoul 15
Istanbul 13
San Francisco 13
Caxias do Sul 12
Taizhou 12
Bogotá 11
Council Bluffs 11
Monmouth Junction 11
Munich 11
Recife 11
São José do Rio Preto 11
Toronto 11
Zhengzhou 11
Amman 10
Cagliari 10
Casablanca 10
Dallas 10
Fortaleza 10
Frankfurt am Main 10
Guayaquil 10
Nairobi 10
Quito 10
Augusta 9
Brno 9
Campinas 9
Contagem 9
Dhaka 9
Goiânia 9
Johannesburg 9
Auburn Hills 8
Campo Grande 8
Falkenstein 8
Joinville 8
Lanzhou 8
Manaus 8
Albissola Marina 7
Asunción 7
Franca 7
Guarujá 7
Juiz de Fora 7
Leawood 7
Los Angeles 7
Nuremberg 7
Rio Grande 7
Salvador 7
São Bernardo do Campo 7
Volta Redonda 7
Aracaju 6
Barbianello 6
Betim 6
Caracas 6
Catanduva 6
Totale 4.337
Nome #
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors 110
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 102
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties. 98
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems 98
Approcci terapeutici contro il cancro. Tradizione e innovazione. 95
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers 93
Composti farmaceutici 93
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists 91
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues 89
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors 89
Preparation of thieno[3,2-h]cinnolinones as matrix metalloproteinase inhibitors 89
CAPITOLO 41. Antielmintici 89
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 88
Development and characterization of novel cannabinoid derivatives based on diarylpyridazine scaffold. 88
Tricyclic thienopyrazole derivatives as ligands for cannabinoid receptors: synthesis and biological evaluation 87
The organic chemistry of drug design and drug action 86
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 86
Chemistry of tricyclic-based heterocycles as useful scaffolds for phosphodiesterase 10A ligands 85
Correction to Synthesis and antineoplastic evaluation of novel unsymmetrical 1,3,4-oxadiazoles 85
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6- tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide and analogue derivatives. 83
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism 83
Tricyclic pyrazoles. Part 3. Synthesis, biological evaluation and molecular modelling of analogues of the cannabinoid antagonist NESS 0327 83
Chiral pyridine N-oxides useful ligands for asymmetric catalysis 82
Pharmaceutical Compounds 82
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands 81
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands 80
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2 ',4 '-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyra zole-3-carboxamide 80
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 79
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking 77
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS 77
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 76
Oxadiazoles having anti proliferative activity 75
Novel diazabicycloalkane delta opioid agonists 75
Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzolglindazole-based ligands for cannabinoid receptors 74
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 74
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 74
Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors 74
Synthesis, modelling, and m-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes 73
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists 73
Synthesis and cytotoxicity of substituted 2-benzylnaphth[2,3-d]imidazoles 73
Synthesis and cytotoxicity evaluation of thiophene analogues of 1-methyl-2,3-bis(hydroxymethyl)benzo[g]indole bis[N-(2-propyl)carbamate] 72
Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors 72
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands 72
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 72
Synthesis and application in asymmetric copper(I)-catalyzed allylic oxidation of a new chiral 1,10-phenantroline derived from pinene 71
Manuale di chimica farmaceutica. Progettazione, meccanismo d'azione e metabolismo dei farmaci 71
Synthesis of chiral C2-symmetric 1,10-phenanthrolines from naturally occurring monoterpenes 71
Synthesis and anti-HIV-1 activity of new delavirdine analogues carrying arylpyrrole moieties 71
Synthesis and tumor cell lines inhibition of 1,3,4.oxadiazoles linked to tricyclic pyrroles 71
Pharmaceutical compounds 70
Sintesi di 1,10-fenantroline chirali a simmetria C2 derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 70
Design, Synthesis and preliminary biological data of new ligands for neuronal nicotinic acetylcholine receptors 70
Oxadiazoles having antiproliferative activity 69
Pharmaceutical compounds 69
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides 68
Pirazoli triciclici: sintesi e valutazione biologica di ligandi per i recettori cannabinoidei con struttura diidroindenopirazolica contenenti differenti sostituenti carbossammidici 68
Oxadiazoles having antiproliferative activity 67
Different classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 67
A survey of Recent Patents on CB2 Agonists in the Management of Pain 67
An overview on different classes of viral entry and respiratory syncitial virus (RSV) fusion inhibitors 66
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives 66
Pharmaceutical compounds 65
Ring-fused pyrazole derivates as ligands for cannabinoid receptors: synthesis and investigation of structure-activity relationships 65
Pharmaceutical compounds 65
Ossadiazoli ad attività antiproliferativa 64
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella sostituzione allilica palladio-catalizzata 63
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications 63
I farmaci antivirali. Dalla progettazione all’impiego terapeutico. 63
Tricyclic pyrazole derivatives as cannabinoid receptor antagonist 62
Design of a new class of chiral C2-symmetric dipyridylmethane ligands and their application in asymmetric catalysis 62
Synthesis of biologically active bridged diazabicycloheptanes 61
Pharmaceutical compounds 61
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori μ degli oppioidi 60
Pharmaceutical compounds 60
Substituted 3,8-diazabicyclo[3.2.1]octane compounds 60
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[ 3.1.1]heptanes as novel potent dopamine uptake inhibitors 60
RNA-viruses. Enzymatic and receptorial inhibitors. Research signpost keral, India, (RNA-viruses. Enzymatic and recptoral inhibitors. 59
Diazacyclic compounds having affinity for opioid receptors 59
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists 59
NESS06SM reduces body weight with an improved profile relative to SR141716A 59
Synthesis and μ-opioid receptor affinity of heteroaromatic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 59
New tricyclic pyrazole derivatives as CB1 antagonists having improved activity towards food intake and weight control 58
Chimica farmaceutica 58
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors 58
Synthesis and biological evaluation of novel CB2 ligands 58
3-(5-Phenyl[1,3,4]oxadiazol-2-yl)-1H-benzo]g]indole and related compounds: synthesis and cytotoxic acitivities 58
Synthesis and cytotoxic activities of 3-(5-phenyl-[1.3.4]oxadiazol-2-yl)-1H-benzo[g]indole and related compounds 56
Sintesi di nuovi diazatriciclodicani (DTDs). Effetto della variazione strutturale della catena cinnamilica sulla μ-affinità e sull’analgesia oppioide 56
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 56
Tricyclic thieno-pyrazoles as new potent and selective CB2 ligands 55
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti agonisti per i recettori µ degli oppioidi 55
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 54
Sintesi e affinità per i recettori oppioidi di nuovi N3-propionil-N6-naftilprop(en)il-3,6-diazabiciclo[3.3.1]eptani 54
Synthesis and μ-opioid receptor affinity of fused .bicyclic analogues of N-3(9)-Arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes (DBNs) 53
Pharmaceutical compounds 53
Pharmaceutical Compounds 53
Sintesi di 1,10-fenantroline chirali a simmetria C2derivati da monoterpeni naturali quali utili leganti per la catalisi asimmetrica 53
Synthesis and analgesic-antiinflammatory activities of novel acylarylhydrazones with a 5-phenyl-4-R-3-pyrrolyl-acyl moiety 53
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes 52
Antiviral activity of benzotriazole based derivatives 51
Totale 7.102
Categoria #
all - tutte 37.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 0 0 0 0 0 38 109 3
2020/2021920 110 5 138 12 111 32 124 23 128 135 82 20
2021/2022572 67 6 9 7 8 5 28 48 51 37 61 245
2022/20231.271 130 78 27 229 110 210 2 161 228 8 56 32
2023/2024396 58 26 15 7 37 81 1 55 3 4 50 59
2024/20253.111 20 20 186 59 124 117 277 583 1.351 374 0 0
Totale 8.239